Positive Aware HIV Drug Chart

News

Lenacapavir becomes first FDA-approved HIV preventive drug

Lenacapavir becomes first FDA-approved HIV preventive drug: All about it

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a twice-yearly injectable drug developed for adults and teenagers.

KFF Health News · 1h

FDA Green-Lights Gilead Sciences’ Groundbreaking HIV Prevention Drug

A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.

BioSpace · 23h

Gilead Wins Historic Approval for Twice-Yearly HIV Drug

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement. “Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic.”

WebMD2mon

Side Effects of HIV and AIDS Drugs

Photo credit: Dann Tardif/Getty Images. Here is an overview of some of the common and more severe HIV drug side effects. The following chart lists some HIV medication side effects that are ...

Wall Street Journal1mon

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug

Gilead Sciences rose 2% in early trading, after the biotech reported positive data for a long-acting HIV prevention drug that promises to be a big seller. The drug, called lenacapavir, was 96% ...

AZ Central1mon

Medicaid in Arizona adds HIV prevention drug to approved list starting Oct. 1

Starting on Oct. 1, PrEP will be added to the AHCCCS list of approved drugs that do not require ... woman in her 30s who tested positive for HIV. It turned out she'd been in a relationship with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results